Observatory on Treatment Adhesion in Patients Suffering From Hepatitis C Chronic Treated With ViraferonPeg® Injected / Rebetol® in Conjunction With a Psychotherapeutic Assistance Program
Phase of Trial: Phase III
Latest Information Update: 23 Dec 2013
At a glance
- Drugs Peginterferon alfa-2b (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Registrational; Therapeutic Use
- Sponsors Schering-Plough
- 16 Sep 2009 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.
- 16 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 29 Sep 2008 Planned end date changed from 1 Apr 2009 to 1 Jun 2009 as reported by Clinicaltrials.gov.